DCAT Summit at Lugano > Agenda
DCAT Sustainability Summit at Lugano, Switzerland
Agenda & Key Takeaways
11:00 SUMMIT CHECK-IN
13:30 (1:30 PM) WELCOME & OPENING REMARKS—DCAT
- Donna Gruol, President, Lone Fox Endeavors, and DCAT First Vice President
- Kelsey Achenbach, Vice President, Pharma and Medical Nutrition, dsm-firmenich, and DCAT Second Vice President
13:35 (1:35 PM) SUSTAINABILITY: THE BUSINESS IMPERATIVE—A GLOBAL OVERVIEW
Companies are recognizing sustainability as a strategic and operational imperative, leading them to re-evaluate their end-to-end operations. An executive briefing on the major issues—both the risks and opportunities— throughout the entire value chain.
- Markus Hayek, Partner, Life Sciences, Kearney
- Sarah Kerrigan, Director, Sustainability, Kearney
14:15 (2:15 PM) SUSTAINABILITY METRICS & REPORTING (ROUNDTABLE)
Bio/pharma companies and their suppliers must address rising expectations among investors, shareholders, and customers in setting and meeting sustainability targets while complying with key policy initiatives, including the European Green Deal. How does your company rate? An expert panel gives practical insight on the metrics, common reporting standards, and requirements most important in assessing a company’s environmental and sustainability-related performance.
- Anette Quincy, Global Director of Sector Initiatives, EcoVadis
- Nelleke Barning, Vice President, Global Head of Sustainability, dsm-firmenich
- Luca Dalla Torre, Chief Legal Officer, Siegfried
- Moderator: Kelsey Achenbach, Vice President, Pharma and Medical Nutrition, dsm-firmenich, and DCAT Second Vice President
15:15 (3:15 PM) NETWORKING SESSION
15:45 (3:45 PM) THE SUSTAINABILITY EDGE: SUPPLIER BEST PRACTICES (ROUNDTABLE)
Adapting development, manufacturing, and distribution capabilities within a globalization sustainability framework is a major challenge—from maximizing access to affordable clean energy to upgrading large-scale manufacturing sites to meeting customers’ needs while aligning facilities within complex organizations. Leading organizations provide first-hand experience and best practices on how they are meeting that challenge internally and collaboratively through external partnerships and pharma-industry specific initiatives.
- Christian Seufert, President, Capsules Division, Lonza
- Simon Gerrard, Director, Renewables & Carbon Advisory, Energize
- Moderator: Donna Gruol, President, Lone Fox Endeavors, and DCAT First Vice President
17:15 (5:15 PM) WELCOME—REGIONAL SPEECHES
Remarks from high-ranking municipal, state, and business leaders from Switzerland.
- Michele Foletti, Mayor of the City of Lugano
- Stefano Rizzi, Director of Economy Division of the Canton of Ticino
- Kamil Tamiola, CEO, Peptone
17:30 (5:30 PM) DAY 1 CLOSING COMMENTS
- Charles Davies, CEO, Brand-Nu Laboratories (a Caldic Company), and DCAT President
18:00 (6:00 PM) COCKTAIL NETWORKING RECEPTION
- Palazzo dei Congressi (Lugano Convention Centre)
8:15 BREAKFAST ~ COFFEE/NETWORKING
9:00 — 12:00 INDUSTRY SOLUTIONS: (PODIUM PRESENTATIONS)
Leading executives from both bio/pharma companies and suppliers provide practical insights on how their companies are managing and implementing sustainability throughout the bio/pharma manufacturing value chain. This solution-based session will provide valuable frameworks and options for other organizations facing similar challenges. Key areas to be addressed:
- Management (collaboration; governance; game theory in application to business strategy; climate-related financial task force in managing risk; and project tracking / road maps).
- Operations (digital technologies; continuous manufacturing; facility design for improved emissions, wastewater management and energy resource allocation; and decarbonization).
- Measuring outcomes (key metrics, including Science Based Targets initiative (SBTi) validation).
Speaker lineup and session times below.
9:00 INDUSTRY SOLUTIONS: PART I (PODIUM PRESENTATIONS)
- Olivier Roland, Associate Vice President, Energy, Environmental Sustainability and Integrated Logistics Procurement, MSD
- Donal Kelleher, Executive Director, External Manufacturing, MSD.
- Matthew Yamatin, Enterprise Sustainability Program Director, Thermo Fisher Scientific
- Christian Hebich, CEO, Arcondis
- Nick Hutchinson, Head of Market Development and Global Sustainability, Evotec
10:10 MORNING NETWORKING & COFFEE
10:40 INDUSTRY SOLUTIONS: PART II (PODIUM PRESENTATIONS)
- Nicole Schumacher, Sustainability & Compliance, Lead, Global Procurement, F. Hoffman-La Roche Ltd.
- Pascal Michoux, Vice President, Global EH&S, Teva API
- Oliver Viehmann, Principal, TWS Partners AG
- Sucheth Davuluri, Vice Chairman and CEO, Neuland Laboratories
12:15 NETWORKING & LUNCHEON
13:15 (1:15 PM) SUSTAINABILITY & PRODUCT DEVELOPMENT (ROUNDTABLE)
Incorporating sustainability throughout the product lifecycle is crucial, but what is the best way to begin? Industry experts provide practical ways to overcome the challenge of upstream product development while meeting sustainability obligations—from laboratory design to product design and development, to adapting and evolving existing facilities and development processes.
- Dr. Samantha Gordine, Sustainability Solutions Lead, Arcondis
- Dr. Arne Kloke, President, Alliance To Zero & Head of Sustainability, SCHOTT Pharma
- Dora Rio, Global Head of Sustainability, SHL Medical AG
- Moderator: To Be Announced
14:45 (2:45 PM) AFTERNOON NETWORKING & REFRESHMENTS
15:15 (3:15 PM) CEOs UNPLUGGED (ROUNDTABLE)
Leading executives give a C-suite view of the strategic role of sustainability and how it factors into shareholder value, reporting obligations, investments, credit/risk profiles & funding, supply-chain planning & implementation, and compliance priorities.
- Christian Hebich, CEO, Arcondis
- Paolo Tubertini, CEO, Olon SpA
- Piero Poli, CEO, Rivopharm SA
- Pierfrancesco Morosini, CEO, ICROM SRL, and DCAT Director
- Luca Sartorello, Chief Sustainability Officer, ICE S.p.a.
- Sucheth Davuluri, Vice Chairman and CEO, Neuland Laboratories
- Waldo Mossi, CEO, HAS Healthcare Advanced Synthesis
- Moderator: Paolo Magri, CEO, BioSeutica and Past DCAT President
16:45 (4:45 PM) KEYNOTE CLOSING ADDRESS—CARBON DIRECT
Nili Gilbert, CFA, CAIA, is the Vice Chairwoman of Carbon Direct, a leader in scaling carbon management into a global industry through climate investment, technology, and client advisory.
She is also Chair of the Glasgow Financial Alliance for Net Zero’s (GFANZ) Advisory Panel of technical experts, as well as a member of its CEO Principals Group. In addition to serving as a Chairwoman of both the David Rockefeller Fund and the Synergos Institute Investment Committees, Nili is an Independent Board Director of Brookfield Asset Management. She is also a Senior Advisor at Boston Consulting Group (BCG) and a member of the Clinton Global Initiative Advisory Council.
Previously, she was Co-Founder and Portfolio Manager of Matarin Capital, which became one of the larger women-owned asset managers in the US. She also previously served as a member of the State of California’s Climate-Related Financial Risk Advisory Group, the Social Mission Board of Seventh Generation, a wholly-owned subsidiary of Unilever, and the TED Vision Council.
18:00 (6:00 PM) COCKTAILS & DINNER Lugano Arte e Cultura (Lugano Cultural Arts Center)
Thank you to our sponsors
